|
Current News Releases
8/22/2011: Wall Street Daily: This Biotech Discovery Causes HIV to Self-Destruct.
PHV 8.17.2011 | link
8/17/2011: Fast Company: A New Plan To Mutate HIV Out Of Existence.
PHV 8.17.2011 | link
7/20/2011: Forbes: Embracing the Enemy-Most HIV drugs work by halting the virus' reproduction. Biotech firm Koronis has a different idea.
PHV 7.20.2011 | link
6/13/2011: Forbes: With Koronis, Is A Cure For HIV On The Horizon?
PHV 6.13.2011 | link
5/31/2011: LA Times: ViaCyte progresses toward trials in stem cell diabetes treatment.
PHV 5.31.2011 | link
3/21/2011: Daily Express: Koronis May Bring HIV Hope to Market.
PHV 3.21.2011 | link
3/16/2011: Bioworld: Koronis Looking for Financing for HIV Viral Decay Accelerator.
PHV 3.16.2011 | link
3/14/2011: Koronis Pharmaceuticals exploring alternatives for financing the late-stage development of KP-1461 against HIV.
PHV 3.14.2011 | link
2/22/2011: Genetic Engineering News Podcast with Mark Fromhold, Ph.D., Koronis Pharmaceuticals. The significance of the KP-1461 clinical trial findings.
PHV 2.22.2011 | link
1/26/2011: Wedbush Securities: The Potential Disruptive Effect that Koronis Pharmaceuticals Could Have on the Existing HIV Market
PHV 1.26.2011 | link
1/19/2011: Koronis Pharmaceuticals - Clinical Trial Results Demonstrate Promise for First Non-suppressive HIV Drug
PHV 1.17.2011 | link
9/9/2010: Koronis Pharmaceuticals Announces Late-Breaker Oral Presentation on HIV Therapeutic Candidate KP-1461 at 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
PHV 9.23.2010 | link
9/1/2010: 2010 & Beyond: A look at forthcoming new HIV meds and novel ways that treatment could advance over the coming decade.
PHV 9.23.2010 | link
4/29/2010: Koronis Pharmaceuticals to Present at 2010 BIO International Convention
PHV 4.29.2010 | link
|
Archived News Releases
10/28/2009: Novocell is the Recipient of a Disease Team Award for $20 Million from the California Institute for Regenerative Medicine to Develop a Stem Cell Therapy for the Treatment of Diabetes
PHV 10.30.2009 | link
7/31/2009: Need for Novel Approaches to Treating HIV Still Exists (Koronis)
PHV 7.31.2009 | link
5/19/2009: Koronis Pharmaceuticals' Scientific Advisory Board Confirms KP-1461 Clinical Drug Activity, HIV Ablation
PHV 5.19.2009 | link
05/11/2009: Novocell Names John West Chief Executive Officer
PHV 5.14.2009 | link
05/06/2009: Novocell Receives Grant Awards from California Institute for Regenerative Medicine for Stem Cell Therapy Development
PHV 5.14.2009 | link
2/09/2009: HIV Mutates to Death With New Drug
PHV 2.10.2009 | link
12/22/2008: TransMolecular Receives Orphan Drug Designation for 131I-TM601
PHV 2.9.2009 | link
12/19/2008: Novocell Announces Non-Exclusive Drug Discovery Collaboration with Pfizer
PHV 2.9.2009 | link
12/9/2008: Novocell Announces Collaboration with World-Renowned Stem Cell Researcher
PHV 2.9.2009 | link
11/25/2008: Novocell CEO to Head Juvenile Diabetes Research Foundation (JDRF)
PHV 2.9.2009 | link
9/30/2008: Koronis Pharmaceuticals Announces Appointment of Prominent HIV Researcher Courtney Fletcher, Pharm. D., to Scientific Advisory Board and Jeff Parkins as VP, Clinical Development
PHV 10.28.2008 | link
9/29/2008: Dosing Initiated in TransMolecular's Phase 1/2 Clinical Trial
PHV 11.5.2008 | link
9/17/2008: Novocell Awarded Landmark U.S. Patents for Innovative Stem Cell Technologies
PHV 10.27.2008 | link
6/15/2008: Today's biopharma venture capital challenge: Risk-sharing models versus risk avoidance
PHV 7.1.2008 | link
6/9/2008: Novocell's Emmanuel Baetge, Ph.D., Featured in Forbes cover story: "Stem Cells Get Real"
PHV 7.1.2008 | link
12/27/2007: Pacific Horizon Could Reap Illumigen Sale Windfall
PHV 1.5.2008 | link
12/26/2007: Cubist Pharmaceuticals Acquires Illumigen Biosciences
PHV 12.27.2007 | link
10/17/2007: Seattle Times-Cubist gets option to acquire Illumigen
PHV 10.17.2007 | link
10/16/2007: Cubist Pharmaceuticals Announces Exclusive Option to Acquire Illumigen Biosciences
PHV 10.16.2007 | link
9/25/2007: New Kind of Antiretroviral, KP-1461; Clinical Trial Recruiting. Interview with Stephen Becker, M.D.
PHV 9.25.2007 | link
8/10/2007: Fierce Biotech-Emerging Drug Developers: Koronis Pharmaceuticals
PHV 9.25.2007 | link
7/16/2007: Novocell Raises $25 Million
PHV 7.25.2007 | link
6/28/2007: Koronis Pharmaceuticals Raises $20 Million
PHV 7.3.2007 | link
6/26/2007: Koronis Pharmaceuticals Begins Phase 2a Proof of Concept Study of KP-1461
PHV 7.3.2007 | link
|
© Pacific Horizon Ventures, 2012.
|
|
